Cargando…

Overexpression of secretory clusterin (sCLU) induces chemotherapy resistance in human gastric cancer cells by targeting miR-195-5p

Recent focus has turned to secretory clusterin (sCLU) as a key contributor to chemoresistance of anticancer agents, but the role of sCLU on chemotherapy drug response to gastric cancer cells is not fully understood. Previous research found that sCLU was overexpressed in the induced multidrug-resista...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mu, Lihua, Yang, Fengxia, Guo, Dong, Li, Ping, Zhang, Maoshen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161562/ https://www.ncbi.nlm.nih.gov/pubmed/32250192 http://dx.doi.org/10.1080/21655979.2020.1747825

Ejemplares similares

ATM Regulates Insulin-Like Growth Factor 1-Secretory Clusterin (IGF-1-sCLU) Expression that Protects Cells against Senescence
por: Luo, Xiuquan, et al.
Publicado: (2014)

sCLU as prognostic biomarker and therapeutic target in osteosarcoma
por: Ma, Jinfeng, et al.
Publicado: (2019)

Secreted clusterin (sCLU) regulates cell proliferation and chemosensitivity to cisplatin by modulating ERK1/2 signals in human osteosarcoma cells
por: Huang, Hai, et al.
Publicado: (2014)

sCLU regulates cisplatin chemosensitivity of lung cancer cells in vivo
por: Ma, Guoliang, et al.
Publicado: (2015)

Preliminary Study on Clusterin Protein (sCLU) Expression in PC-12 Cells Overexpressing Wild-Type and Mutated (Swedish) AβPP genes Affected by Non-Steroid Isoprenoids and Water-Soluble Cholesterol
por: Pająk, Beata, et al.
Publicado: (2019)

Reduced secreted clusterin as a mechanism for Alzheimer-associated CLU mutations
por: Bettens, Karolien, et al.
Publicado: (2015)

A pan-cancer analysis reveals role of clusterin (CLU) in carcinogenesis and prognosis of human tumors
por: Fu, Yizhe, et al.
Publicado: (2023)

Expression of miR-195 is associated with chemotherapy sensitivity of cisplatin and clinical prognosis in gastric cancer
por: Ye, Rui, et al.
Publicado: (2017)

Plasma Clusterin and the CLU Gene rs11136000 Variant Are Associated with Mild Cognitive Impairment in Type 2 Diabetic Patients
por: Cai, Rongrong, et al.
Publicado: (2016)

Low dose IR-induced IGF-1-sCLU expression: a p53-repressed expression cascade that interferes with TGFβ1 signaling to confer a pro-survival bystander effect
por: Klokov, Dmitry, et al.
Publicado: (2012)

CluMan
por: Lopienski, Sebastian
Publicado: (2008)

miR-195-5p regulates multi-drug resistance of gastric cancer cells via targeting ZNF139
por: Nie, Hongfeng, et al.
Publicado: (2018)

Hsa_circ_0063804 enhances ovarian cancer cells proliferation and resistance to cisplatin by targeting miR-1276/CLU axis
por: You, Jun, et al.
Publicado: (2022)

miR-103/miR-195/miR-15b Regulate SALL4 and Inhibit Proliferation and Migration in Glioma
por: Chen, Li-Ping, et al.
Publicado: (2018)

miR-25-3p inhibition impairs tumorigenesis and invasion in gastric cancer cells in vitro and in vivo
por: Ning, Liang, et al.
Publicado: (2020)

ZNF367 Inhibits Cancer Progression and Is Targeted by miR-195
por: Jain, Meenu, et al.
Publicado: (2014)

Decreased expression of miR-195 mediated by hypermethylation promotes osteosarcoma
por: Sun, Tianhao, et al.
Publicado: (2022)

Clinical value of combined detection of miR-1202 and miR-195 in early diagnosis of cervical cancer
por: Yang, Xielan, et al.
Publicado: (2019)

CluMan - Cluster management toolsuit
por: Siket, M, et al.
Publicado: (2010)

LncRNA LUADT1 sponges miR-195 to prevent cardiac endothelial cell apoptosis in sepsis
por: Zhang, Zhimin, et al.
Publicado: (2020)

Circulating miR-30a, miR-195 and let-7b Associated with Acute Myocardial Infarction
por: Long, Guangwen, et al.
Publicado: (2012)

miR-195 is a key regulator of Raf1 in thyroid cancer
por: Wang, Fangzheng, et al.
Publicado: (2015)

Serum miR‐195‐5p is upregulated in gestational diabetes mellitus
por: Wang, Jianping, et al.
Publicado: (2020)

Serum miRNAs panel (miR-16-2*, miR-195, miR-2861, miR-497) as novel non-invasive biomarkers for detection of cervical cancer
por: Zhang, Yujuan, et al.
Publicado: (2015)

Up‐regulation of miR‐195 contributes to cardiac hypertrophy‐induced arrhythmia by targeting calcium and potassium channels
por: Xuan, Lina, et al.
Publicado: (2020)

Oncogenic secretory clusterin in hepatocellular carcinoma: Expression at early staging and emerging molecular target
por: Zheng, Wenjie, et al.
Publicado: (2016)

Therapeutic role of meloxicam targeting secretory clusterin-mediated invasion in hepatocellular carcinoma cells
por: Zhong, Jingtao, et al.
Publicado: (2018)

Ultraconserved element uc.372 drives hepatic lipid accumulation by suppressing miR-195/miR4668 maturation
por: Guo, Jun, et al.
Publicado: (2018)

Ligand-Dependent Downregulation of Guanylyl Cyclase/Natriuretic Peptide Receptor-A: Role of miR-128 and miR-195
por: Khurana, Madan L., et al.
Publicado: (2022)

CLU: A new algorithm for EST clustering
por: Ptitsyn, Andrey, et al.
Publicado: (2005)

CLU blocks HDACI-mediated killing of neuroblastoma
por: Subramanian, Chitra, et al.
Publicado: (2010)

Dampening HOTAIR sensitizes the gastric cancer cells to oxaliplatin through miR‐195‐5p and ABCG2 pathway
por: Luo, Yaomin, et al.
Publicado: (2023)

miR-195 Inhibits EMT by Targeting FGF2 in Prostate Cancer Cells
por: Liu, Chunhui, et al.
Publicado: (2015)

Data on the expression of PEPCK in HepG2 hepatocytes transfected with miR-195
por: Yang, Won-Mo, et al.
Publicado: (2017)

miR-195 enhances the radiosensitivity of colorectal cancer cells by suppressing CARM1
por: Zheng, Li, et al.
Publicado: (2017)

miR-195 Serves as a Tumor Suppressor in the Progression of Liposarcoma by Targeting OSBP
por: Cao, Ye, et al.
Publicado: (2020)

Tumor suppressive effects of the pleiotropically acting miR-195 in colorectal cancer cells
por: Forouzan Jahromi, Zahra, et al.
Publicado: (2019)

Demethylation of miR‐195 suppresses prostate cancer cell proliferation, migration and invasion
por: Ma, Xiaokun, et al.
Publicado: (2020)

miR-195/miR-497 Regulate CD274 Expression of Immune Regulatory Ligands in Triple-Negative Breast Cancer
por: Yang, Lianzhou, et al.
Publicado: (2018)

Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer
por: McAnena, Peter, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3e3dn7n70fti1v1adegjegl2go